Fenavari
Fenavari has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jul 24, 2026: “Dose-Dependent Efficacy of a Combined Standardized Extract of Fenugreek and Shatavari on Menopausal Symptoms: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study”.
1 paper studies it4 findingsUpdated
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Both Fenavari 300 mg and 500 mg significantly reduced MRS total scores from Day 14 through Day 84 compared with placebo (Fenavari 300 mg: -8.26 ± 0.46, p < 0.0001; Fenavari 500 mg: -10.40 ± 0.40, p < 0.0001; placebo: -4.09 ± 0.47).”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: OmniActive Health Technologies
- 4 of 4 findings with company ties
- Human trial1
Studies in people
1 study gave fenavari to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases menopausal symptoms-8.26 ± 0.46 (300 mg), -10.40 ± 0.40 (500 mg) vs -4.09 ± 0.47 (placebo) down: Decreases hot flashes up: Increases estradiol | Randomized trial84 days | 150 peopleWomen40-60 yearsMidlife adults; Postmenopausal women; Patient cohorts | Women's health reports (New Rochelle, N.Y.), Jul 24, 2026 |
What did studies of fenavari find?
4Studies of fenavari measured 4 outcomes, among them follicle stimulating hormone, estradiol and hot flashes.
Follicle stimulating hormone
downin humans1
1 study
Follicle stimulating hormone
downin humans1
Fenavari decreases follicle stimulating hormone in humans.
“Serum estradiol increased significantly with corresponding reductions in FSH by Day 84 compared with placebo.”
Human trialstandardized extract84 daysfemalesn = 150
Women's health reports (New Rochelle, N.Y.)
Estradiol
upin humans1
1 study
Estradiol
upin humans1
Fenavari increases estradiol in humans.
“Serum estradiol increased significantly with corresponding reductions in FSH by Day 84 compared with placebo.”
Human trialstandardized extract84 daysfemalesn = 150
Women's health reports (New Rochelle, N.Y.)
Hot flashes
downin humans1
1 study
Hot flashes
downin humans1
Fenavari decreases hot flashes in humans.
“Both doses of Fenavari significantly reduced hot flashes and night sweats by Day 84.”
Human trialstandardized extract300 mg or 500 mg84 daysfemalesn = 150
Women's health reports (New Rochelle, N.Y.)
Menopausal symptoms
downin humans1
1 study
Menopausal symptoms
downin humans1
Fenavari decreases menopausal symptoms in humans (-8.26 ± 0.46 (300 mg), -10.40 ± 0.40 (500 mg) vs -4.09 ± 0.47 (placebo)).
“Both Fenavari 300 mg and 500 mg significantly reduced MRS total scores from Day 14 through Day 84 compared with placebo (Fenavari 300 mg: -8.26 ± 0.46, p < 0.0001; Fenavari 500 mg: -10.40 ± 0.40, p < 0.0001; placebo: -4.09 ± 0.47).”
Human trialstandardized extract300 mg or 500 mg84 daysfemalesn = 150
Women's health reports (New Rochelle, N.Y.)